Cargando…
Preclinical and Clinical Evaluation of Magnetic-Activated Cell Separation Technology for CTC Isolation in Breast Cancer
Circulating tumor cell (CTC) count is an independent prognostic factor in early breast cancer. CTCs can be found in the blood of 20% of patients prior to neoadjuvant therapy. We aimed to assess the suitability of magnetic-activated cell separation (MACS) technology for isolation and cytological char...
Autores principales: | Lozar, Taja, Jesenko, Tanja, Kloboves Prevodnik, Veronika, Cemazar, Maja, Hosta, Violeta, Jericevic, Anja, Nolde, Natasa, Grasic Kuhar, Cvetka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522616/ https://www.ncbi.nlm.nih.gov/pubmed/33042837 http://dx.doi.org/10.3389/fonc.2020.554554 |
Ejemplares similares
-
The Biology and Clinical Potential of Circulating Tumor Cells
por: Lozar, Taja, et al.
Publicado: (2019) -
Morphological Features of Breast Cancer Circulating Tumor Cells in Blood After Physical and Biological Type of Isolation
por: Jesenko, Tanja, et al.
Publicado: (2021) -
Association of Circulating Tumor Cells, Megakaryocytes and a High Immune-Inflammatory Environment in Metastatic Breast Cancer
por: Grašič Kuhar, Cvetka, et al.
Publicado: (2023) -
The prognostic significance of tumor-immune microenvironment in ascites of patients with high-grade serous carcinoma
por: Miceska, Simona, et al.
Publicado: (2023) -
Digital ischemic events related to gemcitabine: Report of two cases and a systematic review
por: Kuhar, Cvetka Grasic, et al.
Publicado: (2010)